BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19782110)

  • 21. A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran.
    Haghi AM; Khoramizade MR; Nateghpour M; Mohebali M; Edrissian GH; Eshraghian MR; Sepehrizadeh Z
    Korean J Parasitol; 2012 Mar; 50(1):15-21. PubMed ID: 22451729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp.
    Pacheco MA; Elango AP; Rahman AA; Fisher D; Collins WE; Barnwell JW; Escalante AA
    Infect Genet Evol; 2012 Jul; 12(5):978-86. PubMed ID: 22414917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.
    Rojas Caraballo J; Delgado G; Rodriguez R; Patarroyo MA
    Vaccine; 2007 May; 25(18):3713-21. PubMed ID: 17240494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
    Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720.
    Saul A; Hensmann M; Sattabongkot J; Collins WE; Barnwell JW; Langermans JA; Wu Y; Long CA; Dubovsky F; Thomas AW
    Parasite Immunol; 2007 Oct; 29(10):525-33. PubMed ID: 17883455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
    Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
    Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.
    Giraldo MA; Arevalo-Pinzon G; Rojas-Caraballo J; Mongui A; Rodriguez R; Patarroyo MA
    Vaccine; 2009 Dec; 28(1):7-13. PubMed ID: 19782110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on the search for a Plasmodium vivax vaccine.
    Herrera S; Corradin G; Arévalo-Herrera M
    Trends Parasitol; 2007 Mar; 23(3):122-8. PubMed ID: 17258937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivax.
    Levitus G; del Portillo HA
    Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():81-4. PubMed ID: 7565138
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasmodium vivax malaria vaccine development.
    Arévalo-Herrera M; Herrera S
    Mol Immunol; 2001 Dec; 38(6):443-55. PubMed ID: 11741694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination for vivax malaria: targeting the invaders.
    Polley SD; McRobert L; Sutherland CJ
    Trends Parasitol; 2004 Mar; 20(3):99-102. PubMed ID: 16676415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platform for Plasmodium vivax vaccine discovery and development.
    Valencia SH; Rodríguez DC; Acero DL; Ocampo V; Arévalo-Herrera M
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1(Suppl 1):179-92. PubMed ID: 21881773
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.